Alessia Spirlì

Statistics

Publications

Citations

136

H-Index

Active since

2014

Affiliations

Royal Marsden NHS Foundation Trust(Current)

Dana-Farber Cancer Institute

Oxford University Hospitals NHS Trust

University College London Hospitals NHS Foundation Trust

St Vincent's Hospital Melbourne

Alessia Spirlì is an author at Royal Marsden NHS Foundation Trust specializing in relapsed multiple myeloma, refractory multiple myeloma, and pharmacotherapy.

Publications per year

2014–2023

Publications

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

Paul G. Richardson, Suzanne Trudel, Rakesh Popat et al. · New England Journal of Medicine · 2023 · 85 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Mezigdomide (CC-92480), a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD), Combined with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Dose-Expansion Phase of the CC-92480-MM-001 Trial

Paul G. Richardson, Suzanne Trudel, Hang Quach et al. · Blood · 2022 · 26 citations

Medicine, Pharmacology, Pharmacotherapy +12

WNK3 abrogates the NEDD4-2-mediated inhibition of the renal Na<sup>+</sup>-Cl<sup>−</sup>cotransporter

Dagmara Lagnaz, Juan Pablo Arroyo, María Chávez‐Canales et al. · American Journal of Physiology-Renal Physiology · 2014 · 25 citations

Life Sciences, Biochemistry, Molecular Biology +9

1–3 of 3